Joe Glass, PhD, MSW, is an associate investigator at Kaiser Permanente Washington Health Research Institute (KPWHRI). Before joining KPWHRI in July 2016, he was an assistant professor at the University of Wisconsin–Madison School of Social Work.
Dr. Glass’ research seeks to understand how effective health care interventions for unhealthy alcohol and drug use can reach more people. His research seeks to answer these questions:
Much of Dr. Glass’ recent work, funded by the National Institute on Alcohol Abuse and Alcoholism, National Institute on Drug Abuse, and Kaiser Permanente, is studying approaches for routinely using smartphone and web-based treatments for unhealthy alcohol and drug use in health care. After receiving an MSW from the University of Michigan, Dr. Glass spent three years as a social worker at the Veterans Affairs Ann Arbor Healthcare System. As a licensed clinical social worker in a large mental health clinic, he developed expertise in social work case management and evidence-based treatments for anxiety, depression, and substance use disorders. Much of his research is driven by his clinical experiences, considering the many people struggling with both mental health difficulties and unhealthy substance use who have yet to receive addiction treatment.
Dr. Glass is an affiliate assistant professor of health services and of psychiatry and behavioral sciences, at the University of Washington.
Busch AC, Shivaram M, Glass JE, Hetzel S, Gugani SP, Gassman M, Krahn D, Deyo B, Brown RT. Pre-discharge injectable vs. oral naltrexone to improve post-discharge treatment engagement among hospitalized veterans with alcohol use disorder: a pilot proof-of-concept study. Alcohol Clin Exp Res. 2017 Jul;41(7):1352-1360. doi: 10.1111/acer.13410. Epub 2017 Jun 12. PubMed
Busch AC, Denduluri M, Glass J, Hetzel S, Gugnani SP, Gassman M, Krahn D, Deyo B, Brown R. Predischarge injectable versus oral naltrexone to improve postdischarge treatment engagement among hospitalized veterans with alcohol use disorder: a randomized pilot proof-of-concept study. Alcohol Clin Exp Res. 2017 Jul;41(7):1352-1360. doi: 10.1111/acer.13410. Epub 2017 Jun 12. PubMed
Glass JE, Andréasson S, Bradley KA, Wallhed Finn S, Williams EC, Bakshi A, Gual A, Heather N, Tiburcio Sainz M, Benegal V, Saitz R. Rethinking alcohol interventions in health care: a thematic meeting of the International Network on Brief Interventions for Alcohol & Other Drugs (INEBRIA). Addict Sci Clin Pract. 2017 May 10;12(1):14. doi: 10.1186/s13722-017-0079-8. PubMed
Glass JE, McKay JR, Gustafson DH, Kornfield R, Rathouz PR, McTavish FM, Atwood AK, Isham A, Quanbeck A, Shah D. Treatment seeking as a mechanism of change in a randomized controlled trial of a mobile health intervention to support recovery from alcohol use disorders. J Subst Abuse Treat. 2017 Jun;77:57-66. doi: 10.1016/j.jsat.2017.03.011. Epub 2017 Mar 30.
Glass JE, Rathouz PJ, Gattis M, Joo YS, Nelson JC, Williams EC. Intersections of poverty, race/ethnicity, and sex: alcohol consumption and adverse outcomes in the United States. Soc Psychiatry Psychiatr Epidemiol. 2017 Mar 27. doi: 10.1007/s00127-017-1362-4. [Epub ahead of print]. PubMed
Amy Lee describes how the LHS Program is helping KP Washington track and improve treatment for opioid use disorder.
Drs. Lapham and Bradley find frequency of cannabis use can be tied to other behavioral health patterns and needs.
Health Affairs blog, Mar 11, 2020